192 related articles for article (PubMed ID: 30830647)
1. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals.
Pawłowska I; Pawłowski L; Krzyżaniak N; Kocić I
BioDrugs; 2019 Apr; 33(2):183-191. PubMed ID: 30830647
[TBL] [Abstract][Full Text] [Related]
2. The growing role of biologics and biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference.
Crespi-Lofton J; Skelton JB
J Am Pharm Assoc (2003); 2017; 57(5):e15-e27. PubMed ID: 28689708
[TBL] [Abstract][Full Text] [Related]
3. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.
O'Callaghan J; Bermingham M; Leonard M; Hallinan F; Morris JM; Moore U; Griffin BT
Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961
[TBL] [Abstract][Full Text] [Related]
4. A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners.
Foreman E; Patel H; Siderov J; Harchowal J; Bubalo J; Chan A
J Oncol Pharm Pract; 2020 Apr; 26(3_suppl):22-32. PubMed ID: 32268828
[TBL] [Abstract][Full Text] [Related]
5. Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey.
Beck M; Michel B; Rybarczyk-Vigouret MC; Levêque D; Sordet C; Sibilia J; Velten M
MAbs; 2017; 9(2):383-390. PubMed ID: 27929743
[TBL] [Abstract][Full Text] [Related]
6. Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey.
Mohd Sani N; Aziz Z; Kamarulzaman A
BioDrugs; 2023 Jan; 37(1):109-120. PubMed ID: 36571697
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' Perspectives of Biosimilars: A Systematic Review.
Mohd Sani N; Aziz Z; Panickar R; Kamarulzaman A
BioDrugs; 2022 Jul; 36(4):489-508. PubMed ID: 35776294
[TBL] [Abstract][Full Text] [Related]
8. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.
Barbier L; Vandenplas Y; Simoens S; Declerck P; Vulto AG; Huys I
J Pharm Policy Pract; 2021 Jun; 14(1):53. PubMed ID: 34158128
[TBL] [Abstract][Full Text] [Related]
9. Assessment of pharmacists' views on biosimilar naming conventions.
Fernandez-Lopez S; Kazzaz D; Bashir M; McLaughlin T
J Manag Care Spec Pharm; 2015 Mar; 21(3):188-95. PubMed ID: 25726028
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist biosimilar survey reveals knowledge gaps.
Stevenson JG; McCabe D; McGrath M; McBride A
J Am Pharm Assoc (2003); 2023; 63(2):529-537.e7. PubMed ID: 36437154
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey.
Marín-Jiménez I; Carrascosa JM; Guigini MA; Monte-Boquet E
Farm Hosp; 2021 Jul; 45(5):240-246. PubMed ID: 34806583
[TBL] [Abstract][Full Text] [Related]
12. Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study.
Rupert DJ; Jordan AM; Ziemian MA; Brown RM; Fleming NS; Lefebvre RC
BioDrugs; 2022 Sep; 36(5):645-655. PubMed ID: 35962911
[TBL] [Abstract][Full Text] [Related]
13. Biosimilar Naming Conventions: Pharmacist Perceptions and Impact on Confidence in Dispensing Biologics.
Tomaszewski D
J Manag Care Spec Pharm; 2016 Aug; 22(8):919-26. PubMed ID: 27459654
[TBL] [Abstract][Full Text] [Related]
14. Clinical and conventional pharmacy services in Polish hospitals: a national survey.
Pawłowska I; Pawłowski L; Kocić I; Krzyżaniak N
Int J Clin Pharm; 2016 Apr; 38(2):271-9. PubMed ID: 26739130
[TBL] [Abstract][Full Text] [Related]
15. Awareness and Knowledge of Pharmacists toward Biosimilar Medicines: A Survey in Jordan.
Oqal M; Hijazi B; Alqudah A; Al-Smadi A; A Almomani B; Alnajjar R; Abu Ghunaim M; Irshaid M; Husam A
Int J Clin Pract; 2022; 2022():8080308. PubMed ID: 35832802
[TBL] [Abstract][Full Text] [Related]
16. Position Paper from the Portuguese Association of Hospital Pharmacists for biosimilar therapeutic antibodies.
Goncalves J; Matos de Brito P; Batista A; Feio J; Machado F; Aperta J; Ascensão I; Pires V; Oliveira C; Armandina Pontes R; Alcobia A; Paulo Cruz J; Lampreia Guerreiro S; Farinha H; Margarida Freitas A; Caetano M; Almeida P; Costa B; Oliveira C; Campos C; Madureira B; Cavaco M; Catarino H;
J Clin Pharm Ther; 2017 Apr; 42(2):239-243. PubMed ID: 27859438
[TBL] [Abstract][Full Text] [Related]
17. Healthcare professionals' perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study.
Aladul MI; Fitzpatrick RW; Chapman SR
BMJ Open; 2018 Nov; 8(11):e023603. PubMed ID: 30455389
[TBL] [Abstract][Full Text] [Related]
18. Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!
Dutta B; Huys I; Vulto AG; Simoens S
BioDrugs; 2020 Apr; 34(2):159-170. PubMed ID: 31792843
[TBL] [Abstract][Full Text] [Related]
19. Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians.
Cohen H; Beydoun D; Chien D; Lessor T; McCabe D; Muenzberg M; Popovian R; Uy J
Adv Ther; 2017 Jan; 33(12):2160-2172. PubMed ID: 27798772
[TBL] [Abstract][Full Text] [Related]
20. Provider and patient knowledge gaps on biosimilars: insights from surveys.
Gibofsky A; Evans C; Strand V
Am J Manag Care; 2022 Nov; 28(12 Suppl):S227-S233. PubMed ID: 36493396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]